Summary Safety Review - Celecoxib - Assessing the Risk of Serious Heart and Stroke Side Effects at High Doses Relative to Other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Health Canada carried out a safety review of all the available evidence to evaluate the risk of side effects related to heart and stroke linked with celecoxib, in comparison to other NSAIDs (diclofenac, ibuprofen, naproxen).

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Résumé de l'examen de l'innocuité - Célécoxib (CELEBREX et génériques) - Évaluation du risque d'effets secondaires graves (troubles cardiaques et accident vasculaire cérébral (AVC)) à doses élevées relativement à d'autres médicaments anti-inflammatoires non stéroïdiens (AINS)
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2017-05-18 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["Résumé de l'examen de l'innocuité", "célécoxib", "examen de l'innocuité", "évaluation", "accidents vasculaires cérébraux", "effets secondaires", "doses élevées", "anti-inflammatoires non stéroïdiens", "AINS", "diclofénac", "ibuprofène", "naproxène"], "en": ["Summary Safety Review", "Celecoxib", "safety review", "assessing", "heart-and-stroke", "side effects", "high doses", "Non-Steroidal Anti-Inflammatory Drugs", "NSAIDs", "diclofenac", "ibuprofen", "naproxen"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source